[CLS] O
Identification O
of O
APC2 O
, O
a O
homologue O
of O
the O
adenomatous B
polyposis I
coli I
tumour I
suppressor O
. O
[SEP] O

[CLS] O
A O
common O
MSH2 O
mutation O
in O
English O
and O
North O
American O
HNPCC B
families O
: O
origin O
, O
phenotypic O
expression O
, O
and O
sex O
specific O
differences O
in O
colorectal B
cancer I
. O
[SEP] O

[CLS] O
For O
both O
sexes O
combined O
, O
the O
penetrances O
at O
age O
60 O
years O
for O
all O
cancers B
and O
for O
colorectal B
cancer I
were O
0 O
. O
[SEP] O

[CLS] O
Complete B
absence I
of I
C7 I
was O
also O
found O
in O
one O
sibling O
who O
had O
the O
clinical O
syndrome O
of O
meningococcal B
meningitis I
and O
arthritis B
as O
a O
child O
and O
in O
this O
siblings O
clinically O
well O
eight O
- O
year O
- O
old O
son O
. O
[SEP] O

[CLS] O
In O
addition O
, O
a O
significant O
excess O
risk O
of O
basal B
cell I
carcinoma I
was O
seen O
( O
standardized O
incidence O
ratio O
35 O
, O
95 O
% O
confidence O
interval O
7 O
. O
2 O
to O
102 O
) O
. O
[SEP] O

[CLS] O
An O
altered O
beta O
- O
alanine O
, O
uracil O
and O
thymine O
homeostasis O
might O
underlie O
the O
various O
clinical B
abnormalities I
encountered O
in O
patients O
with O
DPD B
deficiency I
. O
[SEP] O

